Brief ReportBrief Communication
Open Access
Exenatide’s effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes
Alaaeldin M. Bashier, Elamin I. Abdelgadir, Azza A. Khalifa, Fouzia Rashid, Sona M. Abuelkeir and Fawzi E. Bachet
Saudi Medical Journal November 2014, 35 (11) 1404-1407;
Alaaeldin M. Bashier
Endocrine Division, Medical Department, Dubai Hospital, PO Box 94132, Dubai, United Arab Emirates. Tel. +971 506573574. E-mail. Alaaeldin11@gmail.com
Elamin I. Abdelgadir
Endocrine Division, Medical Department, Dubai Hospital, PO Box 94132, Dubai, United Arab Emirates. Tel. +971 506573574. E-mail. Alaaeldin11@gmail.com
Azza A. Khalifa
Endocrine Division, Medical Department, Dubai Hospital, PO Box 94132, Dubai, United Arab Emirates. Tel. +971 506573574. E-mail. Alaaeldin11@gmail.com
Fouzia Rashid
Endocrine Division, Medical Department, Dubai Hospital, PO Box 94132, Dubai, United Arab Emirates. Tel. +971 506573574. E-mail. Alaaeldin11@gmail.com
Sona M. Abuelkeir
Endocrine Division, Medical Department, Dubai Hospital, PO Box 94132, Dubai, United Arab Emirates. Tel. +971 506573574. E-mail. Alaaeldin11@gmail.com
Fawzi E. Bachet
Endocrine Division, Medical Department, Dubai Hospital, PO Box 94132, Dubai, United Arab Emirates. Tel. +971 506573574. E-mail. Alaaeldin11@gmail.com

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Saudi Medical Journal
Vol. 35, Issue 11
1 Nov 2014
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.